Esophagoscopes and gastroscopes market seen reaching $2.48 billion by 2030

The esophagoscopes and gastroscopes market is projected to rise from $1.77 billion in 2025 to $1.88 billion in 2026, with growth tied to rising gastrointestinal disease rates and wider use of endoscopic procedures. The Business Research Company sees the market reaching $2.48 billion by 2030 as demand grows for minimally invasive diagnostics, disposable devices and advanced imaging.

Why it matters: - Esophagoscopes and gastroscopes are central to diagnosing and treating upper gastrointestinal conditions. - Rising demand for early detection and minimally invasive procedures is expanding use in hospitals and outpatient settings. - Growth in this market tracks broader pressure on healthcare systems from digestive diseases, including inflammatory bowel disease.

What happened: - The Business Research Company published a report on the esophagoscopes and gastroscopes market on Aug. 6, 2026. - The market is expected to grow from $1.77 billion in 2025 to $1.88 billion in 2026, a 6.2% compound annual growth rate. - The report forecasts the market will reach $2.48 billion by 2030, at a 7.2% compound annual growth rate. - The report is available through a free sample and the full market report.

The details: - Esophagoscopes and gastroscopes are specialized endoscopes used to examine the esophagus, stomach and the beginning of the small intestine. - The devices support diagnosis, medical guidance and therapeutic procedures such as polyp removal and stent placement. - The report cites rising gastrointestinal disorders, broader use of endoscopic diagnosis, growth in gastroenterology units, better awareness of early disease detection and more specialized endoscopy staff as current growth drivers. - Future growth is linked to demand for minimally invasive therapeutic procedures, investment in endoscopic imaging technology, broader use of disposable endoscopes, more outpatient diagnostics and tighter patient safety and infection control priorities. - Major market trends include high-definition imaging endoscopes, single-use devices, expanded therapeutic endoscopy and stricter infection prevention standards. - Inflammatory bowel disease is a key demand driver because these devices are used to diagnose and monitor the condition. - A March 2023 study in the Journal of the Canadian Association of Gastroenterology projected IBD incidence in Canada would rise from 825 cases per 100,000 people in 2023 to 1,075 per 100,000 by 2035. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, a company scoring matrix, Excel forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables.

Between the lines: - The market mix suggests buyers are prioritizing clearer imaging, lower infection risk and procedures that reduce hospital stays. - Disposable and single-use devices point to continued pressure from infection prevention, especially in procedures that require close patient contact. - Regional growth outside North America signals more spending on endoscopy capacity in faster-developing healthcare systems.

What's next: - The market’s near-term direction will likely depend on adoption of high-definition imaging, single-use endoscopes and outpatient diagnostic workflows. - Growth will also hinge on how quickly healthcare systems expand access to gastroenterology services and advanced endoscopy equipment. - The report frames infection control and patient safety as key themes likely to shape purchasing decisions through 2030.

The bottom line: - Esophagoscopes and gastroscopes are moving from a stable medical device niche into a faster-growing market powered by disease burden, technology upgrades and demand for less invasive care.